Mecamylamine – a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disorders | Semantic Scholar
@article{Bacher2009MecamylamineA, title={Mecamylamine – a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disorders}, author={Ingrid Bacher and Becky S. Wu and Douglas Ronald Shytle and Tony P. George}, journal={Expert Opinion on Pharmacotherapy}, year={2009}, volume={10}, pages={2709 - 2721}, url={https://api.semanticscholar.org/CorpusID:25690407} }
Two independent Phase II clinical trials recently confirmed mecamylamine's hypothesized antidepressant activity and suggest that it may be effective as an augmentation pharmacotherapy for SSRI treatment resistant major depression.